Diagnosis of Alzheimer’s disease based on virtual environments by Fernandez Montenegro, Juan Manuel & Argyriou, Vasileios
 © 2015 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses,
in any current or future media, including reprinting/republishing this material for advertising or promotional
purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted
component of this work in other works
http://dx.doi.org/10.1109/IISA.2015.7388023
Diagnosis of Alzheimer's disease based on 
Virtual Environments 
Juan Manuel Fernández Montenegro and Vasileios Argyriou 
Faculty of Science, Engineering and Computing 
Kingston University 
Kingston upon Thames, UK 
J.Fernandezmontenegro@kingston.ac.uk, Vasileios.Argyriou@kingston.ac.uk
Abstract—Alzheimer's screening tests are currently used by 
doctors as part of a thorough patient examination. These tests are 
performed periodically in specific time intervals trying to 
estimate the patient’s condition and stage as early as possible. 
This work proposes a novel e-health Alzheimer’s screening test 
based on virtual environments using new immersive technologies 
combined with advanced Human Computer Interaction (HCI) 
systems. These new tests are focused on the immersion of the 
patient in a virtual room, in order to mislead and deceive the 
patient’s mind. As a result, two new tests are introduced 
demonstrating the wide range of screening mechanisms that 
could be designed using virtual environments. The proposed tests 
are focused on the evaluation of memory loss related to common 
objects, recent conversations and events, the diagnosis of 
problems in expressing and understanding language and the 
ability to differentiate between virtual worlds and reality. The 
proposed screening tests were evaluated and tested using both 
patients and healthy adults in a comparative study with state-of-
the-art Alzheimer’s screening tests.  
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I.  INTRODUCTION
Alzheimer is a dementia disease that usually affects elder 
people with the number of cases increasing significantly over 
the last decades. Dementia is a syndrome characterised by the 
decline of mental skills such as memory, reasoning, language 
or perceptual interpretation. Alzheimer is the most common 
type; accounts for an estimated 60 to 80 percent of cases, and 
one of the most noticeable symptoms is the difficulty learning 
new information. In addition, when the disease advances, there 
are other symptoms such as disorientation, mood and 
behaviour changes; confusion about events, date and place; 
suspicious about family, friends and caregivers; and difficulty 
speaking, writing and walking [1]. 
According to the World Health Organization, 1.43% of the 
estimated deaths around the world in 2030 will be caused by 
Alzheimer's disease or other dementias. The main 
characteristics of dementia are the decline of mental abilities 
[2] and people with dementia live five years on average [3].
Currently, when Alzheimer’s disease (AD) is diagnosed, the
neuronal damage is spread enough to make it irreversible [4].
Therefore, it is important to detect dementia at very early
stages in order to reduce the deterioration speed.
In addition to the increasing mortality due to Alzheimer, the 
cost of dementia is another issue to take into consideration. The 
worldwide cost of dementia estimated in 2010 was US$604 
billion [5] and it was estimated to increase 85% by 2030. These 
costs account for around 1% of the world’s gross domestic 
product. Therefore, it is essential to develop affordable 
diagnosis and support tools limiting the increasing cost of 
dementia. The fact of being able to provide affordable and 
quality services, affects the whole health system. As a result, 
one of the proposed initiatives is focused on the 
implementation of e-health (the use of Information 
Communication Technology (ICT)) solutions reducing the cost 
trying to make the health systems universally accessible [6]. 
Amongst the e-health range of advantages, there are the 
improvement of the patients’ lifestyle, the quality of care and 
efficiency (time saved) or the possibility of reducing the 
transfer time of medical data such as diagnostics. 
In order to detect Alzheimer, different types of invasive and 
non-invasive tests are available. Invasive methods require 
obtaining data from the interior of the patient’s body using 
injections, endoscopy, etc. These tests are not always safe and 
comfortable for the patient, while some of them are unbearably 
painful. On the other hand, non-invasive tests are harmless and 
despite the fact that some of them require the use of external 
devices during a certain period of time, these methods are more 
convenient during the diagnosis process [7]. 
The most common non-invasive Alzheimer tests for 
diagnosis are cognitive tests. These are question/task/problem 
based trying to measure patient’s cognition. Cognition can be 
defined as the use of the information that has been previously 
collected by a person to make behavioural decisions [8]. 
Cognitive or Aptitude tests have high accuracy when it comes 
to Alzheimer’s detection. Nevertheless, one of their 
weaknesses is the evaluation of cognitive reserve [4]. Cognitive 
reserve is the capacity of the brain to compensate brain 
damage. Another well know problem is the adaptability of the 
test according to the IQ of the patient since most of the tasks 
that integrate an Alzheimer’s detection cognitive test usually 
are too simple to evaluate high IQ patients. The use of 
computerised tests helps to create intelligence adaptable 
cognitive tests [9]. Moreover, based on the available 
technology, it is possible to design new types and more 
effective tests using for example virtual environments (VEs). 
Virtual environments (VEs) provide additional advantages to 
cognitive tests, since it is possible to immerse the patient in a 
controlled situation, [10, 11, 12]. 
In this paper, we propose novel cognitive and executive 
function based, non-invasive screening tests for early 
Alzheimer’s diagnosis implemented as an e-health tool. These 
new tests are conducted in a virtual room due to the flexibility 
to create different tasks and the flow provided by VEs [10, 12]. 
As a result, an innovative and cost efficient e-health 
Alzheimer’s detection application is introduced.  
The remainder of this paper is organised as follows: section 
2 describes previous related work on Alzheimer’s diagnosis. 
Section 3 analyses the proposed methodology and in section 4 
details on the evaluation process and the obtained results are 
presented. Section 5 gives some conclusion remarks.  
II. PREVIOUS WORK 
Early stage dementia detection has significant importance 
in order to reduce the progress speed [13]. The main types of 
tests can be separated to non-cognitive and cognitive tests. 
Cognitive tests encompass the methods that evaluate patients’ 
cognition and whose procedures are non-invasive and easy to 
implement. Non-cognitive test is regarded any other method, 
invasive or non-invasive, used to detect and diagnose dementia.  
Regarding the non-cognitive approaches, in [1, 14] some of 
the methods used to detect dementia are based on defining 
potential biomarkers that are acquired through invasive 
techniques. Other non-cognitive techniques presented in [15, 
16] that provide accurate results are based on Magnetic 
Resonance Imaging (MRI). These techniques compare the head 
MRI data of the patient with the corresponding data of patients 
with Alzheimer using machine learning techniques. About the 
non-cognitive Alzheimer detection methodologies, monitoring 
approaches have been considered in the past. For example, as it 
was suggested in [13] sensors in patients’ homes are used to 
monitor their behaviour and to identify certain events.  
Despite the large range of dementia detection tests, the 
most common tests for early detection are the cognitive ones. 
These tests are based on problem solving tasks and questions, 
in order to detect a cognitive impairment. The Mini Mental 
State Examination (MMSE) is one of the most well-known and 
used tests [17]. The results provided by this test demonstrate 
high accuracy and specificity. Nevertheless, the results show a 
ceiling effect, since the test is not complex enough for high IQ 
patients [17]. Saint Louis University Mental Status (SLUMS) 
examination is another screening tool used to detect mild 
dementia similar to MMSE [18]. On the other hand, there are 
other cognitive tests focused mainly on a single cognitive task. 
For example, the memorisation of interacting objects in the 
Visual Association Test (VAT) [19] or the detection of the 
prevalence of the right ear when sounds are memorised by 
Alzheimer's patients during the Dichotic Listening test [20, 21]. 
Recently, due to the new advances on computer 
technologies, Virtual Environments (VEs) started to become 
part of medical tests and rehabilitation therapies. The work 
presented by I. Tarnanas, et al. in [11] demonstrates that the 
use of VEs is beneficial when it comes to early dementia 
detection. It is possible to improve the results from previous 
cognitive tests since it reduces the floor and the ceiling effects, 
creating tests that adapt to the patients’ IQ; and it is possible to 
increase the immersion of the patient in the task that is in 
progress. Their work uses large screens to display the 
environment and some depth sensors to recognise the gestures 
of the patients’ body. This approach requires the patient to 
move to the location where the facilities for this test are 
available, due to the fact that the components are not portable 
and cost efficient making it inappropriate for e-health 
applications.  
In our work, a novel non-invasive Alzheimer’s detection 
screening test based on VEs is proposed. The Virtual 
Environment created for this test is a room that the patients can 
recognise and feel comfortable, such as the doctor office, a 
living room, etc.  The use of new immersive technologies such 
as virtual reality glasses provides a huge improvement in 
immersing the subjects in a VE. The created tool is the first 
Alzheimer’ detection screening test that provides a full 
immersion in Virtual Environments implying that the patients 
are able to be more focused on the tasks, while additional 
information related to the environment-patient interaction is 
obtained. Also, it is possible to adapt some of the tasks to the 
patient’s IQ level during the test, avoiding the ceiling effect. 
The test is based on the examination of cognitive abilities. 
Therefore, the test is question and task based, trying to provide 
a user friendly and comfortable environment for the patients. 
Furthermore, the proposed tests do not consider only memory 
tasks, but introduce novel approaches based on the concept of 
differentiating between reality and a virtual world. 
III. METHODOLOGY 
Due to the fact that the new tests are based on virtual 
environment immersion, the technology chosen is related to 
games development. Thus, VR glasses are the devices used to 
increase the immersion, whereas a depth camera is utilised to 
track the patients' movements and animate their avatars (see 
figure 1). Since, Alzheimer’s patients are mainly elder people; 
all tasks are performed seated on a chair requiring only 
minimal movements. Virtual reality glasses, depth sensor and a 
computer are the tools required to perform the tests. These 
tools are affordable and they can be reused by other patients, 
resulting in a low cost Alzheimer’s detection application. The 
virtual reality glasses provide an extra pair of lenses for 
nearsighted users to avoid wearing their glasses with the virtual 
reality glasses. 
The main scene was designed such as to recreate the 
doctor's office or any other real room that the patient can 
recognise (e.g. office, living room), as we can see in figure 2. 
Then, the tests were defined taking advantage of the virtual 
environment versatility, such as the absence of physical limits. 
Regarding the real environment, the patient is sitting on a 
comfortable chair about 2 meters in front of the depth sensor 
and is helped to place on the Virtual Reality glasses (see 
figures 3 and 4). Once the patient feels comfortable with the 
glasses, we proceed with the tests. The doctor (or test 
supervisor) has to be in front of the computer locally or 
remotely, in order to control the software application and has to 
take notes during the process typing details that may be useful 
later, since it is possible to obtain in that way extra information 
about the patient’s behaviour. Despite most of the tests are 
automatic and the patient only has to follow the instructions, 
some actions, such as starting a new task or playing sounds, 
requires the interaction of the doctor/instructor in order to 
provide enough time to the patient to perform the actual tasks 
or to add a degree of randomness and adaptability to the 
patient. 
All the proposed tests should be performed under the 
supervision of a healthy person following the instructions on 
the screen or the test’s information sheets. Despite the fact that 
the test could be monitored by any person without mental 
impairments, it is recommendable that the supervisor during 
the tests to be a doctor either locality or remotely, since 
additional information may be obtained during the whole 
process. In this work, two novel tests are introduced: Virtual 
Objects Memorisation and Virtual vs Real Sounds. 
 
Fig. 1. Virtual Reality glasses (Oculus Rift DK2) and Depth sensor (Microsoft 
Kinect 2 sensor) are the devices required to perform the tests. 
 
   
 
Fig. 2 Virtual Reality Room: Top down; Side; and Corner view. 
 
 
(a)                                             (b) 
Fig. 3  (a) Top down view showing the position of the devices, and the 
location of the patient and the supervisor. Around the patient should be space 
to avoid collation with any real objects. (b) Side view showing the position of 
the devices, and the location of the patient and the supervisor. The depth 
sensor should be located at approximately 1 meter above the floor. The patient 
has to be approximately 2 meters away from the depth sensor in order to be in 
the view range. 
 
A. Virtual Objects Memorisation test (VOM) 
This test is formed by memory tasks and it is split into three 
steps. The first step of the memory test is the recognition of six 
different virtual objects. The objects are common used during 
daily activities making them easily identified and recognised. 
The objective of this first task is to check if the patient has 
problems in recognising quotidian objects (see figure 5). Once 
all the objects are recognised, a virtual monitor displays all of 
them in specific positions (the positions of these objects are the 
ones where they normally are located on a desk). Therefore, the 
patient is asked to memorise the objects but nothing is 
mentioned about their position. 
During the second step, the subject is asked about the 
objects located at specific positions, in order to check the visual 
and the associative memory of the patient. In more details, the 
desk is shown in front of the patient and a number appears in 
the position, where an object was located and a list of the six 
possible objects is provided (see figure 5c). The subjects are 
asked about the object that was located in the position indicated 
by the number and they have to select the name of the correct 
object. The fact that the objects were located in logical 
positions should help the user to select the right answers. 
Finally, in the last task, interacting objects are placed in the 
virtual room and have to be located and memorised by the 
patient. Then, one of the objects is shown and the subject has to 
recall its interacting couple and their functionality. Once the 
third stage is completed, there is an extra task associated with 
the first step, where the patient is asked to recall the objects 
that were shown. The aim of the last two tasks is to evaluate 
the patient’s short-term memory incorporating interacting 
objects and their functionalities. So, the novel part here is 
focused mainly on the combination of interacting objects with 
their functionalities. 
 
Fig. 4. Early detection Test setup. The patient is sat in front of the depth 
sensor, wearing the VR glasses. The supervisor (or the doctor) monitors the 
test from the computer or remotely as an e-health application. 
 
Also, it should be mentioned that in order to proceed 
through the test, the subject has to select amongst different 
options. This selection is performed by aiming towards the 
desired option using the direction of view (scope), as we can 
see in figure 5. Therefore, the patients have to move slightly 
the head to fulfil the tasks.  
This test provides in total 21 points, if all tasks are 
completed successfully. Each point is associated to the 
recognition of the objects, the recall of their position and the 
recall of the objects themselves and their functionality. 
B. Virtual vs Real Sounds test (VRS) 
The main objective of this test is to detect if the patient is 
able to discern between real and virtual sounds. Different 
sounds are played during the test, such as a clock ticking, the 
rain sound, etc (see table 1). The patient has to recognise and 
name all the sounds that they listen during the test. This part of 
the test tries to identify if the patient is still able to discern 
events through sounds. In addition, the virtual environment will 
provide some visual clues to help them with the identification 
(see figure 6). Once the subjects have identified all the sounds, 
they are asked about the origin of the sounds. During this stage, 
the source of some sounds is coming either from the virtual 
environment and the real world reproduced by the supervisor. 
This second part requires the patient to recall all the sounds that 
were played and to identify which ones were reproduced by the 
supervisor. 
This test gives a maximum score of 6 points. One point is 
obtained for each object that is recognised and categorised 
properly as real or virtual. 
   





Fig. 5. (a) Virtual Object Memorisation tasks. Objects Recognition task where 
the patient has to identify and select the correct name of the object over the 
table. Virtual Object Memorisation tasks. (b) The objects in their respective 
location is shown in order the patient memorises the objects. (c) Objects 
location task where the patient has to select the name of the object that was 
shown on the screen 
 
 
TABLE I.  SOUNDS PLAYED DURING VRS TEST 
Sound Origen 
Ticking clock sound Virtual 
Fly buzzing sound Virtual 
Breaking glass sound Virtual 
Closing door sound Virtual 
Rain sound Virtual 




Fig. 6 Virtual vs Real Sounds test. The image shows 4 sound sources/clues of 
the 6 used (Clock, fly, rain and mobile phone). The mobile phone sound is 
reproduced by the test supervisor 
IV. RESULTS 
A. Participants 
The 20 participants of this test are aged between 23 and 82 
years old including both healthy people and Alzheimer’s 
patients diagnosed with mild dementia less than year ago. 
Furthermore, Alzheimer’s patients in advanced conditions were 
tested but, the process was not possible to be completed. Half 
the subjects were male and the other half female of whom 
eleven had college or higher educational background and nine 
did not reach high school. It has to be mentioned that one of the 
patients was illiterate so the test was performed orally. 
B. Data 
The main data collected during the experiment are the 
individual scores for each test. As it was explained in section 3, 
each test has a maximum score and each task has associated to 
a different number of points. In more details, regarding the 
recognition and memory tasks each recalled and recognised 
object scores 1 point. The results have been normalised in order 
all the tests have results between 0 and 1. 
In addition, patients have been also tested using other well-
known state of the art Alzheimer screening tests in order to 
perform a comparative study and allow the evaluation of the 
proposed novel non-invasive diagnosis screening tests. All the 
tests were computerised so the patients have to use the 
computer through the whole process retaining also the same 
conditions among all tests. The screening tests used in our 
comparative study are Dr. Oz Memory Quiz [18, 22]; Visual 
Association Test [19]; and Dichotic Listening Test (DLT) [20]. 
C. Results 
 The mean results for each test in relation to the subject’s 
health status are shown in Table 2. It is observed that healthy 
patients have achieved results close to the maximum score of 
each test and the Alzheimer’s patients have obtained 
significantly lower scores in comparison with the health 
participants. For instance, healthy subjects have obtained a 
mean of .92482 whereas the Alzheimer’s subject has scored 
.23810 in the Virtual Objects Memorisation test. This 
separation between results is also apparent on the other state of 
the art tests, such as the relation .98684-.37500 (Healthy – 
Alzheimer) on the Dichotic Listening test.  
TABLE II.  MEAN OF THE TESTS REGARDING THE HEALTHY AND 
ALZHEIMER PATIENTS 
TYPE Age DrOz VAT DLT VOM VRS 
Healthy 42.47 .90095 .89473 .98684 .92482 .83331 
Alzheimer 78.00 .52940 .00000 .37500 .23810 .33330 
  
 Table 3 demonstrates that the p-value of the novel tests 
rejects the Null Hypothesis. Therefore, it proves that the novel 
tests’ results are correlated with the healthy and Alzheimer 
status of the patients.   
TABLE III.  T-TEST FOR EACH TEST ACCORDING TO THE HEALTHY AND 
ALZHEIMER'S CASES. THE P-VALUE (SIG. (2-TAILED)) IS LESS THAN 0.01 SO 
THE NULL HYPOTHESIS IS REJECTED 
 
t-test for Equality of Means 
t f Sig. (2-tailed) Mean Difference Std. Error Difference 
DrOz e.v.aa 4.347 18 .000 .3715526 .0854726 
e.v.n.ab . . . .3715526 . 
VAT e.v.a 4.164 18 .001 .8947316 .2148737 
e.v.n.a . . . .8947316 . 
DLT e.v.a 21.333 18 .000 .6118421 .0780741 
e.v.n.a . . . .6118421 . 
VOM e.v.a 7.418 18 .000 .6867211 .0925755 
e.v.n.a . . . .6867211 . 
VRS e.v.a 4.386 18 .000 .5000105 .1139947 
e.v.n.a . . . .5000105 . 
a Equal Variances Assumed 
b Equal Variances Not Assumed 
  
 On the other hand, left part of Table 4 shows that the mean 
of the scores of the tests for subjects aged above 50 years old 
are always lower than the scores obtained by patients under 50 
years old. However, right part of Table 4 demonstrates that the 
correlation of the results and the age of the patients is not clear, 
since the p-values do not reject the Null hypothesis. 
  The correlation between the DrOz, VAT and DLT tests, 
and the novel ones is presented in Table 5, where the Pearson 
correlation has been calculated, including the correlation 
coefficient and the p-value. All the novel tests result high 
correlation value with the existent tests and the p-value 
supports this correlation. 
 
TABLE IV.  MEAN AND STANDARD DEVIATION ACCORDING WITH 2 AGE 
GROUPS (OVER AND UNDER 50 YEARS OLD); AND P-VALUE IN RELATION WITH 
AGE GROUPS 
  a Equal Variances Assumed 
b Equal Variances Not Assumed 
D. Qualitative evaluation of the proposed system 
 At the end of the test, patients were asked to evaluate the 
application. They had to fill a form evaluating the quality of the 
application in terms of interaction; the simplicity of the 
instructions/process and the comfort of the glasses. 
Additionally, the patients had the option to write any additional 
comments about the application. 
 The average evaluation of the application was positive. 
Some of the subjects commented that the glasses were not 
comfortable at the end of the test and that the graphics could be 
improved. Nevertheless, most of the participants evaluated the 
application as motivating and interesting; and the interaction 
and instructions as simple and easy to understand. 
TABLE V.  STATE OF THE ART AND NOVEL TESTS CORRELATION.  
 DrOz VAT DLT VOM VRS 
 DrOz Correlation Coefficient 1.000 .467* .677** .589** .486* 
Sig. (2-tailed) . .038 .001 .006 .030 
N 20 20 20 20 20 
VAT Correlation Coefficient .467* 1.000 .726** .666** .602** 
Sig. (2-tailed) .038 . .000 .001 .005 
N 20 20 20 20 20 
DLT Correlation Coefficient .677** .726** 1.000 .832** .688** 
Sig. (2-tailed) .001 .000 . .000 .001 
N 20 20 20 20 20 
VOM Correlation Coefficient .589** .666** .832** 1.000 .806** 
Sig. (2-tailed) .006 .001 .000 . .000 
N 20 20 20 20 20 
VRS Correlation Coefficient .486* .602** .688** .806** 1.000 
Sig. (2-tailed) .030 .005 .001 .000 . 
N 20 20 20 20 20 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
Table 6 presents the overall evaluation of the tool 
performed by the participants. The interaction with the 
application (keyboard, mouse, depth sensor and virtual reality 
glasses), the quality of the instructions (written and/or oral 
provided by the supervisor) and the comfort of the VR glasses 
was evaluation from 0 points (really bad) to 5 points (really 
good). The evaluation obtained is positive, since the average 
 





DrOz >= 50 8 .816200 .1554446 e.v.aa .033 
< 50 12 .926492 .0509407 e.v.n.ab .088 
VAT >= 50 8 .770825 .3876870 e.v.a .325 
< 50 12 .902775 .1940844 e.v.n.a .395 
DLT >= 50 8 .906250 .2167916 e.v.a .198 
< 50 12 .989583 .0258944 e.v.n.a .314 
VOM >= 50 8 .797638 .2516588 e.v.a .052 
< 50 12 .952383 .0574379 e.v.n.a .128 
VRS >= 50 8 .729138 .1979503 e.v.a .061 
< 50 12 .861092 .0962259 e.v.n.a .113 
result of all the categories is above 3 points, with elder people 
being more enthusiastic with new technologies probably due to 
the completely new to them features and capabilities.  
 
TABLE VI.  TOOL EVALUATION BY THE PARTICIPANTS. FOUR 
CHARACTERISTICS WERE EVALUATED FROM 0 (VERY BAD) TO 5 (VERY GOOD) 
TYPE Mouse Inter Kinect Inter Instructions VR Glasses 
>= 50 4.17 4.00 4.43 3.86 
< 50 4.33 3.33 4.17 3.50 
 
V. CONCLUSIONS 
Virtual Environments (VEs) start to be part of medical 
treatments or diagnosis methods, and they have been proved to 
be considerably positive to apply techniques in secure and 
controlled environments; helping to increase the effectivity of 
the related tests. These facts have been further proved with our 
application, since the results obtained show that it is possible to 
create an accurate e-health screening Alzheimer’s diagnostic 
system. In this work novel methods for detection of 
Alzheimer's disease based on Virtual Environments were 
introduced. The flexibility of VEs has demonstrated to solve 
the ceiling effect present in most used cognitive test. The 
proposed tests are focused on the evaluation of memory loss 
related to common objects, recent events, the diagnosis of 
problems in expressing and understanding language and the 
ability to differentiate between virtual worlds and reality. The 
proposed approaches were evaluated in a comparative study 
with well-known state of the art cognitive tests. Finally, a novel 
e-health tool has been introduced and developed that proves the 
benefits of e-health services such as the improvement of 
patient’s daily life, avoiding painful tests; its affordable cost, 
since the difference price of the testing devices in comparison 
with other projects using HCI systems is considerable, 
moreover, the plausible decrease of the VR glasses due to the 
foreseen peak next years; and the wide accessibility that allows 
the patient to be tested at home.  
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